44
Treatment
Table 15. Risk Factors for Abdominal Aortic Aneurysm
Strong Risk Factors Additional Risk Factors
Smoking history Hypertension
Older age Hyperlipidemia
Male sex White race
Family history of abdominal aortic
aneurysm
Inherited vascular connective tissue
disorder
Atherosclerotic cardiovascular disease
6.4.1.1. BP Management in Sporadic TAA
COR LOE
Recommendations
1 B-NR 1. In patients with TAA and an average systolic BP (SBP) of
≥130 mm Hg or an average diastolic BP (DBP) of ≥80 mm
Hg, the use of antihypertensive medications is recommended
to reduce risk of cardiovascular events.
2a C-LD 2. In patients with TAA, regardless of cause and in the absence
of contraindications, use of beta blockers to achieve target BP
goals is reasonable.
2a C-EO 3. In patients with TAA, regardless of etiolog y and in the
absence of contraindications, ARB therapy is a reasonable
adjunct to beta-blocker therapy to achieve target BP goals.
6.4.1.2. Treatment of TAA With Statins
COR LOE
Recommendations
2a C-LD 1. In patients with TAA and imaging or clinical evidence of
atherosclerosis, statin therapy at moderate or high intensity is
reasonable.
2b C-LD 2. In patients with TAA who have no evidence of atherosclerosis,
the use of statin therapy may be considered.
